Skip to main content
Caplight Logo









Novocuff

Novocuff

Private
Mountain View, CaliforniaHealthcare & Life Scienceshttps://www.novocuff.com

Last Round

Series A

Jul 17, 2024

Total Funding Raised

$26.3M

Company Overview

Novocuff is a medical device company that creates innovative solutions to prevent preterm birth, including a minimally invasive device designed to stabilize the cervix and extend pregnancy duration for both singleton and multiple gestation pregnancies.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

preterm birth preventionpreterm birth devicemedical deviceCervical Control Systemfemtechwomen's healthPPROMPreterm Premature Rupture of Membranescervical shorteningnon-surgical devicecervical stabilizationobstetrics devicepivotal clinical trialsingle-use device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Novocuff Comparables

Compare Novocuff with similar companies based on industry and business-model similarity.

Novocuff comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PregnanTech
93%
Cx Therapeutics, Inc.
80%
Dr. Arabin GmbH & Co. KG
74%

Novocuff Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 17, 2024
GrantAug 10, 2023

Key People

Founding team and executive leadership

Donald Lee

Co-Founder & COO

Founding Team

Novocuff Investors

Notable investors and investment history

Novocuff investors
InvestorRounds
March of DimesSeries A
NIH RADxGrant
Avestria VenturesSeries A
RH CapitalSeries A

Novocuff Filings

Explore SEC and related filing metadata, where available.

Novocuff filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Novocuff's valuation, stock price, and market status.

Is Novocuff a public or private company?

Novocuff is a private company.

What is the current stock price of Novocuff?

Novocuff is a private company with no public stock price. Caplight tracks Novocuff's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Novocuff worth (valuation)?

Valuation information for Novocuff is not publicly available.

Can I buy Novocuff stock?

Novocuff shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Novocuff's last funding round?

Novocuff's most recent funding round was Series A on July 17, 2024.

Who are the main investors in Novocuff?

Key investors in Novocuff include March of Dimes, NIH RADx, Avestria Ventures, RH Capital.

Will Novocuff IPO soon?

No public IPO plans have been announced for Novocuff.

How can I track Novocuff secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Novocuff's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMountain View, California
Employee Range10
Year Founded2021
Last FundingJul 17, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?